Board of Directors

» Board of Directors » Marjan Daeipour

Marjan Daeipour

Marjan Daeipour heads J.P. Morgan’s Global Cash Equities healthcare specialist sales for over 15 years, advising internal and external clients on investing in the pharmaceutical, biotech and medical technology sectors. She is the top ranked specialist salesperson across pharmaceutical, medtech and biotech in Extel for the last 8 years and in Institutional Investor since the categories’ introduction in 2017. Prior to the sell side, Marjan was a Global Healthcare portfolio manager at M&G (2001-2003) & pan-European healthcare analyst/PM at JPMAM (1998-2001). She started her career in finance in ’96 managing the proprietary healthcare fund at the Industrial Bank of Japan.

Marjan holds an MSc in Philosophy of Economics from the London School of Economics and a BSc in Biological Sciences from the University of California, Irvine. She has several publications in the field of Immunology based on her research at UCLA Medical Center. Marjan is a CFA Charterholder.